NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-072-2015-0-IE-01 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA IE EP 14841207.5 Issued
NCATS E-072-2015-0-GB-01 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA GB EP 14841207.5 Issued
NCATS E-072-2015-0-EP-10 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA EP National Stage 14841207.5 Issued
NCATS E-072-2015-0-PCT-02 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA PCT PCT PCT/US2014/053756 Expired
NIAID E-219-2016-0-PCT-02 Serum Antibody Assay For Determining Protection From Malaria, And Pre-Erythrocytic Subunit Vaccines PCT PCT PCT/US2014/053745 Expired
NCATS E-072-2015-0-AE-03 DEVICE AND METHODS OF USING DEVICE FOR DETECTION OF HYPERAMMONEMA AE National Stage 215/2016 Pending
NCI E-132-2012-0-US-04 Method of Altering the Immunodominance Hierarchy of HIV Gag by DNA Vaccine Expressing Conserved Regions US National Stage 14/382,281 9415099 Issued PDF
NCI E-257-2014-0-US-01 Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis US 62/043,880 Abandoned
NINDS E-251-2005-0-US-13 SYSTEMS FOR RECOVERY FROM MOTOR CONTROL VIA STIMULATION TO A SUBSTITUTED SITE TO AN AFFECTED AREA US CON 14/471,369 1007-10-16 Issued PDF
NEI E-113-2010-0-US-07 Nitisinone For Treatment Of Oculocutaneous/Ocular Albinism And For Increasing Pigmentation US CON 14/471,142 9364448 Issued PDF
NIA E-049-2001-0-US-23 GLP-1, Exendin-4, Peptide Analogs and Uses Thereof US CON 14/470,528 10941187 Issued PDF
NIA E-224-2014-0-US-01 External Peripheral Vascular Occlusion For Enhanced CardioPulmonary Resuscitation US 62/042,588 Abandoned
NEI E-164-2014-0-US-01 METHODS AND COMPOSITIONS FOR TREATING LEBER CONGENITAL AMAUROSIS US 62/042,703 Abandoned
NIDA E-199-2015-0-US-01 Method And Apparatus For The Capture Of Intra-cellular Activity (Nanofids) US 62/041,028 Abandoned
NCATS E-088-2016-0-CA-03 5-AMINO 4-CYANO SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS INHIBITORS OF HUMAN 12/15-LIPOXYGENASE CA National Stage 2924141 Issued
NIBIB E-005-2012-2-US-05 Multi-Focal Structured Illumination Microscopy Systems and Methods US National Stage 14/380,392 9696534 Issued PDF
NCATS E-088-2016-0-PCT-02 Inhibitors Of 12/15-Lipoxygenase PCT PCT PCT/US2014/052269 Expired
CC E-199-2012-0-US-03 COMPUTED TOMOGRAPHY (CT) - HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) SYSTEM AND/OR METHOD US National Stage 14/380,418 Abandoned
NIAID E-212-2014-0-US-01 Chimeric Antigen Receptor To Control HIV Infection US 62/040,398 Abandoned
NIAID E-219-2014-0-US-03 Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase US National Stage 14/130,384 9593136 Issued PDF
NINDS E-235-2014-0-US-01 BIOMARKERS FOR DIAGNOSIS AND MANAGEMENT OF NEURO-IMMUNOLOGICAL DISEASES US 62/038,530 Abandoned
NICHD E-057-2008-0-IL-49 Use Of Ulipristal For Treating Uterine Fibroids IL DIV 234149 Abandoned
NINDS E-143-2002-1-JP-43 Method For the Treatment of Multiple Sclerosis JP DIV 2014-147314 Abandoned
NIMH E-345-2013-0-PCT-02 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches PCT PCT PCT/US2014/051234 Expired
NIMH E-345-2013-0-EP-05 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches EP National Stage 14756200.3 Abandoned
NIMH E-345-2013-0-AU-03 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches AU National Stage 2014306458 Abandoned
NIMH E-345-2013-0-CA-04 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches CA National Stage 2921405 Abandoned
NIDCR E-066-1996-0-US-11 AAV4 VECTOR AND USES THEREOF US CON 14/459,550 Abandoned
NCI E-117-2011-0-HK-33 Recombinant Immunotoxin Targeting Mesothelin HK DIV 14108273.5 Abandoned
NIAID E-050-1997-1-US-21 DEVICE AND METHOD FOR AMPLIFYING TARGET NUCLEIC ACID US CON 14/456,592 9506105 Expired PDF
NCI E-205-2009-0-US-09 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer US DIV 14/454,820 9522955 Abandoned PDF
NIA E-013-2010-0-AU-09 THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS AU DIV 2014210656 Issued
NCI E-025-2009-0-NZ-22 Ratio Based Biomarkers And Methods of Use Thereof NZ DIV 628463 Issued
NCI E-209-2014-0-US-01 PHOTO-CONTROLLED REMOVAL OF TARGETS IN VITRO AND IN VIVO US 62/034,990 Abandoned
CC E-110-2014-0-US-01 Targeting CD36 Utilizing Synthetic Amphipathic Peptide Antagonists To Prevent Pulmonary Infection, Inflammation And Lung Injury US 62/035,161 Abandoned
NCI E-158-2014-0-US-01 HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR 5T4 AND METHODS OF THEIR USE US 62/034,995 Abandoned
NINDS E-025-2012-0-US-06 Methods of Treating and Preventing Diseases and Disorders of the Central Nervous System US National Stage 14/377,348 9308163 Issued PDF
NCI E-034-2010-0-US-05 Beta-Mannosylceramide and Stimulation of NKT Cell Anti-Tumor Immunity US CON 14/453,829 9168291 Issued PDF
NIDDK E-064-2004-0-JP-57 THE USE OF LEPTIN FOR TREATING HUMAN LIPOATROPHY AND METHOD FOR DETERMINING PREDISPOSITION TO SAID TREATMENT JP DIV 2014-160718 Abandoned
NIDDK E-210-2014-0-US-01 A3 Adenosine Receptor Agonists US 62/033,723 Abandoned
NIAID E-253-2011-4-US-01 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US CON 14/450,773 10047147 Issued PDF
NHLBI E-243-2009-0-US-04 Method For The Treatment Of Pulmonary Disease And Method of Producing Proteins Of Use Therein US DIV 14/450,512 Abandoned
NIA E-205-2006-2-HK-21 Preparation Of R,R- Fenoterol And R,R OR R,S Fenoterol Analogues And Their Use In Treating Congestive Heart Failure HK National Stage 14107948.2 Abandoned
NIAID E-043-2014-1-US-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE US 62/032,886 Abandoned
NCI E-508-2013-2-CA-04 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE CA National Stage 2920017 Abandoned
NCI E-508-2013-2-AU-02 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE AU National Stage 2014296023 Abandoned
NCI E-508-2013-2-GB-15 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE GB EP 14752716.2 Abandoned
NCI E-508-2013-2-FR-14 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE FR EP 14752716.2 Abandoned
NCI E-508-2013-2-DE-13 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE DE EP 14752716.2 Abandoned
NCI E-508-2013-2-EP-06 INHIBITORS OF THE FARNESOID X RECEPTOR AND USES IN MEDICINE EP National Stage 14752716.2 Issued